Bristol Myers Squibb Co
NYSE · Healthcare · Pharmaceutical Preparations · Princeton, NJ
CELG-RI chart
What traders are saying about $CELG-RI
Latest postsBristol Myers Squibb Co news
- Bristol Myers Squibb Explores the CCR8 Pathway to Advance Cancer Immunotherapy
Oncodaily ·
- Bristol Myers Squibb (BMY) Reports 56 Week Pediatric Phase 3 Camzyos Data
Yahoo Finance ·
- Bristol Myers Squibb Australia riders more than double their target for Rare Cancers Australia
PharmaDispatch ·
- Bristol Myers Squibb stock extends Camzyos evidence in adolescents
ad-hoc-news.de ·
- 5 Defensive Dividend Stocks Yielding Up to 8.7% for Retirement Income
247wallst.com ·
- Will Bristol Myers' Growth Brands Offset Eliquis Headwinds?
Yahoo Finance ·
- MRK's 2027 Outlook Challenging, Long-Term Prospects Promising
Yahoo Finance ·
- What Happens To Pfizer Stock If Patent Losses Outpace New Drugs?
trefis.com ·
- Bristol Myers Squibb stock: Camzyos data support pediatric case
ad-hoc-news.de ·
- M Holdings Securities Inc. Buys 45,082 Shares of Bristol Myers Squibb Company $BMY
MarketBeat ·
- Bristol Myers Squibb Company $BMY Stock: Kestra Advisory Services LLC Raises Position
MarketBeat ·
- BioNTech vs. Moderna: The COVID Vaccine Giants Are Entering a New Era. One Stock Could Have the Edge for 2027
fool.com ·
Bristol Myers Squibb Co key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $48.19B | $48.30B | $45.01B | $46.16B |
| Net income | $7.05B | -$8.95B | $8.03B | $6.33B |
| Diluted EPS | $3.46 | $-4.41 | $3.86 | $2.95 |
| Total assets (year end) | $90.04B | $92.60B | $95.16B | $96.82B |
| Cash and equivalents (year end) | $10.21B | $10.35B | $11.46B | $9.12B |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
- 10-Q10-Q
- 8-K8-K
- 10-Q10-Q
- 8-K8-K
- 8-KCURRENT REPORT
- 10-Q10-Q
- 8-K8-K
- DEF 14ADEF 14A
- 10-K10-K
- 8-K8-K
- 8-KCURRENT REPORT
- 8-KCURRENT REPORT
About Bristol Myers Squibb Co
- Ticker
- CELG-RI (NYSE)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Princeton, NJ
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 14272
Frequently asked questions
What exchange is Bristol Myers Squibb Co listed on?
Bristol Myers Squibb Co trades on the NYSE under the ticker symbol CELG-RI.
What industry is Bristol Myers Squibb Co in?
Bristol Myers Squibb Co is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Bristol Myers Squibb Co headquartered?
Bristol Myers Squibb Co's business address on file with the SEC is in Princeton, NJ.
When does Bristol Myers Squibb Co's fiscal year end?
Bristol Myers Squibb Co's fiscal year ends on December 31.
How much revenue did Bristol Myers Squibb Co report?
Bristol Myers Squibb Co reported $48.19B in revenue for calendar year 2025, according to its SEC filings.